Kojima 2021.
Study characteristics | |||
Patient Sampling | Single centre, retrospective, case‐control study that included 179 eyes of 99 consecutive people with keratoconus and suspected keratoconus (68 males and 31 females, mean age 33.48 (SD 15.41) years), who visited the Nagoya Eye Clinic from January 2019 to December 2020 and were tested with an auto‐keratometer (ARK‐1s, Gamagori, Japan, NIDEK). During the same period, 468 eyes of 235 consecutive people (125 men and 110 women; mean age 37.55 (SD 22.70) years) examined for refractive correction were included as normal controls. The control group included people who had no abnormalities on slit‐lamp biomicroscopy examination and corneal topography. | ||
Patient characteristics and setting | People already diagnosed with keratoconus or suspected keratoconus were included. The exact reason why healthy controls visited the centre is unclear. | ||
Index tests | Regression algorithm, modified keratoconus keratometer index (KKI) using 3 variables: steep K‐value, flat K‐value, and astigmatism. logit = 1.284 × steep K (dioptre) − 0.618 × flat K (dioptre) − 3.163 × (0: non‐with‐the‐rule astigmatism; 1: with‐the‐rule astigmatism) − 28.662, KKI = exp(logit)/(1 + exp[logit]). The cut‐off value of 0.461 had been determined previously. | ||
Target condition and reference standard(s) | 2 cornea specialists diagnosed keratoconus through slit‐lamp microscopy and corneal topography. Keratoconus signs found in both slit‐lamp microscopy and corneal topography were classified as keratoconus, while signs found only in corneal topography were classified as suspected keratoconus. Forme fruste keratoconus was defined as an eye with normal corneal topography in the contralateral eye of the keratoconus. The severity of keratoconus was based on the Amsler–Krumeich classification. |
||
Flow and timing | All cases were included in the reference standard and index test. All data were included in a 2 × 2 table. | ||
Comparative | Not applicable | ||
Notes | This research received no external funding. | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | No | ||
Did the study avoid inappropriate exclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Was the model designed in an appropriate manner? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference standard | |||
Is the reference standard likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and timing | |||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Low risk | ||
DOMAIN 5: Comparative | |||
Were different AI tests were developed and interpreted without knowledge of each other. | |||
Are the proportions and reasons for missing data similar for all index tests? | |||